GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (XSWX:YPSN) » Definitions » Research & Development

Ypsomed Holding AG (XSWX:YPSN) Research & Development : CHF0.0 Mil (TTM As of Sep. 2023)


View and export this data going back to 2004. Start your Free Trial

What is Ypsomed Holding AG Research & Development?

Research & Development is the aggregate amount of research and development expenses during the year. Ypsomed Holding AG's Research & Development for the six months ended in Sep. 2023 was CHF0.0 Mil. Its Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 was CHF0.0 Mil.

Ypsomed Holding AG Research & Development Historical Data

The historical data trend for Ypsomed Holding AG's Research & Development can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Ypsomed Holding AG Research & Development Chart

Ypsomed Holding AG Annual Data
Trend Mar14 Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23
Research & Development
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - - -

Ypsomed Holding AG Semi-Annual Data
Mar14 Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23
Research & Development Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - - - - -

Ypsomed Holding AG Research & Development Calculation

This is the expense the company spent on research and development.

Research & Development for the trailing twelve months (TTM) ended in Sep. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF0.0 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Ypsomed Holding AG  (XSWX:YPSN) Research & Development Explanation

If competitive advantage is created by a patent or tech advantage, at some point it will disappear.

High R&D usually dictates high SG&A which threatens the competitive advantage.

Ypsomed Holding AG Research & Development Related Terms

Thank you for viewing the detailed overview of Ypsomed Holding AG's Research & Development provided by GuruFocus.com. Please click on the following links to see related term pages.

Ypsomed Holding AG (XSWX:YPSN) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Ypsomed Holding AG (XSWX:YPSN) » Definitions » Research & Development
Comparable Companies
XSWX:TECN XSWX:SKAN XSWX:CLTN XSWX:VBSN XSWX:STMN ISRG XPAR:EL BDX TSE:7741 XSWX:ALC OCSE:COLO B RMD WST XPAR:DIM TSE:4543 BAX COO HOLX TSE:7733 XTER:AFX
Traded in Other Exchanges
YPSNz:UK
Address
Brunnmattstrasse 6, Burgdorf, CHE, 3401
Website
https://www.ypsomed.com
Ypsomed Holding AG is a Swiss company that develops and manufactures injection and infusion systems that allow patients to self-administer medication. Specifically, the company focuses on ensuring the ease of diabetes and insulin injection. The company offers various products such as pen needles with a unique click-on function. The company operates under two reportable segments: diabetes care and delivery systems goods and services. Diabetes care and delivery systems goods and services compose 55% and 40% of the company's sales, respectively.

Ypsomed Holding AG (XSWX:YPSN) Headlines

No Headlines